Michael A Metzger
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 9SEC | SNDXSyndax Pharmaceuticals Inc | Sell Plan | 32,375484,843 held (−6%) | $24.24 | $785K | -46.8% |
| Jun 2SEC | SNDXSyndax Pharmaceuticals Inc | Sell | 6,847484,843 held (−1%) | $18.99 | $130K | -32.1% |
| Feb 10SEC | SNDXSyndax Pharmaceuticals Inc | Sell | 17,159491,690 held (−3%) | $21.03 | $361K | -38.7% |
| Feb 6SEC | SNDXSyndax Pharmaceuticals Inc | Sell | 7,412508,849 held (−1%) | $20.62 | $153K | -37.4% |
- Sell
CEO Michael A Metzger sold $785K of SNDX at $24.24 — pre-scheduled 10b5-1 plan sale.